Is GeneDx Holdings Corp. overvalued?

GeneDx Holdings Corp. (WGS) — key valuation metrics and fundamentals.

No verdict

Price

$78.46

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.34B

Dividend yield

0.0%

Return on equity

-38.7%

Sector

Healthcare

Fair value compares WGS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks